FDA Needs Dispute Resolution Office At Commissioner Level - Internal Report
Executive Summary
FDA should create a unit within the commissioner's office dedicated to managing disputes between companies or other entities and the agency's centers, a report by agency staffers says
You may also be interested in...
FDA Emphasizes Process Integrity In Questioning Approval Of Knee Device
Drug sponsors trying to gauge how FDA's new leadership might handle controversies surrounding their NDAs received some sobering insight when the agency released its internal assessment of the approval of ReGen Biologics' Menaflex knee repair device.
Do-Over? FDA Orders Look-Back At Knee Device 510(k) Review Process
In a sign of the intense scrutiny CDRH is facing under the new administration, FDA is taking the rare step of performing an internal review of its decision process for a recently 510(k)-cleared device. The inquiry could potentially lead to a "reconsideration" of the clearance, the agency says
Plan B Lightning May Strike Again: Compliance May Not End Political Storm
Perpetual political lightning rod - and emergency contraceptive - Plan B will have more chances to draw strikes to FDA as the agency chooses to comply with a court ruling ordering it to reconsider whether the drug should be available in a truly over-the-counter setting